Loay Kassem

11PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 03, 2025
Social Determinants Associated With the Advanced-Stage Diagnosis of Breast Cancer.

Madonna A Fekry, Loay Kassem, Justin C Yang

|Aug 06, 2025
Impact of BRCA Mutation on Treatment Outcomes of Endocrine Therapy ± CDK4/6 Inhibitors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Systematic Review and Meta-Analysis.

Hamdy A Azim, Hagar Elghazawy, Kyrillus S Shohdy

|Dec 12, 2024
The cost-effectiveness of treatment for high-risk, early-stage, triple-negative breast cancer in Egypt: an analysis of neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant single-agent pembrolizumab.

Bernadette Pöllinger, Amin Haiderali, Min Huang

|Sep 21, 2023
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer.

Hamdy A Azim, Samah A Loutfy, Hatem A Azim

|Jul 17, 2023
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer.

Coralie Poulard, Thuy Ha Pham, Youenn Drouet

|Mar 07, 2022
Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer (mCRC) in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences (EFMS) Consensus Recommendations 2020.

Noha Rashad, Mohamed Abdulla, Mohamed Farouk

Pageof 2

Frequent Collaborators

2 joint publications

Muriel Le Romancer

2 joint publications

Kyrillus S Shohdy

1 joint publications

Boules Eshaak

1 joint publications

Shady Elia Anis